Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability and pharmacokinetics study evaluating NYX-783 with oxycodone in opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• NYX-783
• Oxycodone (oxycodone)

Snippet

Sponsor: Yale University | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED